Concepts (221)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Platelet Glycoprotein GPIIb-IIIa Complex | 11 | 2014 | 100 | 2.650 |
Why?
|
| Blood Platelets | 17 | 2020 | 731 | 1.790 |
Why?
|
| Integrin beta3 | 7 | 2012 | 44 | 1.500 |
Why?
|
| Fibrinogen | 13 | 2014 | 205 | 1.270 |
Why?
|
| Proline | 5 | 2006 | 130 | 1.000 |
Why?
|
| Protein Phosphatase 1 | 5 | 2013 | 79 | 0.990 |
Why?
|
| Platelet Aggregation | 9 | 2014 | 257 | 0.950 |
Why?
|
| Platelet Activation | 3 | 2020 | 116 | 0.940 |
Why?
|
| Protein Phosphatase 2 | 4 | 2013 | 88 | 0.810 |
Why?
|
| Cell Adhesion | 8 | 2014 | 1008 | 0.730 |
Why?
|
| Phosphoprotein Phosphatases | 3 | 2013 | 214 | 0.700 |
Why?
|
| Calcineurin | 2 | 2014 | 128 | 0.560 |
Why?
|
| Signal Transduction | 10 | 2014 | 11965 | 0.550 |
Why?
|
| Thrombosis | 6 | 2020 | 781 | 0.530 |
Why?
|
| Thrombin | 3 | 2013 | 99 | 0.520 |
Why?
|
| Diacylglycerol Kinase | 1 | 2015 | 23 | 0.520 |
Why?
|
| Complement Activation | 1 | 2015 | 94 | 0.500 |
Why?
|
| von Willebrand Factor | 5 | 2014 | 335 | 0.500 |
Why?
|
| Protein Isoforms | 7 | 2014 | 842 | 0.490 |
Why?
|
| Integrin alpha2 | 2 | 2012 | 11 | 0.470 |
Why?
|
| Membrane Microdomains | 1 | 2013 | 80 | 0.450 |
Why?
|
| RNA Interference | 2 | 2015 | 1408 | 0.450 |
Why?
|
| Catalytic Domain | 2 | 2014 | 303 | 0.450 |
Why?
|
| Polymorphism, Genetic | 5 | 2006 | 1450 | 0.400 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2010 | 13 | 0.380 |
Why?
|
| Calcineurin Inhibitors | 1 | 2009 | 68 | 0.330 |
Why?
|
| Endothelial Cells | 1 | 2015 | 1048 | 0.330 |
Why?
|
| Platelet Membrane Glycoprotein IIb | 2 | 2006 | 6 | 0.320 |
Why?
|
| src-Family Kinases | 1 | 2010 | 478 | 0.300 |
Why?
|
| Granulocytes | 3 | 1997 | 224 | 0.290 |
Why?
|
| Prothrombin | 1 | 2006 | 36 | 0.280 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 2006 | 70 | 0.280 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 3 | 2005 | 280 | 0.270 |
Why?
|
| Platelet Adhesiveness | 3 | 2014 | 57 | 0.270 |
Why?
|
| Phosphorylation | 8 | 2014 | 4804 | 0.260 |
Why?
|
| Endothelium, Vascular | 1 | 2009 | 891 | 0.250 |
Why?
|
| Flow Cytometry | 6 | 2014 | 3033 | 0.250 |
Why?
|
| Gene Expression Regulation | 2 | 2013 | 4053 | 0.230 |
Why?
|
| Myosin-Light-Chain Kinase | 1 | 2002 | 72 | 0.220 |
Why?
|
| Cell-Derived Microparticles | 2 | 2014 | 41 | 0.210 |
Why?
|
| Antigens, Human Platelet | 2 | 2008 | 5 | 0.210 |
Why?
|
| Fibronectins | 3 | 2003 | 197 | 0.210 |
Why?
|
| Protein Binding | 6 | 2014 | 3438 | 0.200 |
Why?
|
| Enzyme Activation | 5 | 2012 | 1764 | 0.200 |
Why?
|
| CHO Cells | 6 | 2008 | 311 | 0.200 |
Why?
|
| HEK293 Cells | 3 | 2014 | 1489 | 0.190 |
Why?
|
| Cricetinae | 6 | 2008 | 706 | 0.190 |
Why?
|
| Cell Line | 7 | 2010 | 5114 | 0.170 |
Why?
|
| Animals | 18 | 2015 | 59536 | 0.160 |
Why?
|
| Protein Kinase C | 2 | 2011 | 396 | 0.160 |
Why?
|
| Clot Retraction | 2 | 2012 | 9 | 0.160 |
Why?
|
| P-Selectin | 1 | 1997 | 124 | 0.140 |
Why?
|
| Immunoblotting | 2 | 2010 | 886 | 0.140 |
Why?
|
| Humans | 30 | 2020 | 261506 | 0.140 |
Why?
|
| Stress, Mechanical | 3 | 2014 | 311 | 0.130 |
Why?
|
| Coronary Disease | 1 | 2000 | 764 | 0.130 |
Why?
|
| Mice | 9 | 2014 | 34495 | 0.130 |
Why?
|
| Serum Albumin, Bovine | 1 | 1995 | 83 | 0.130 |
Why?
|
| Indicators and Reagents | 1 | 1995 | 128 | 0.130 |
Why?
|
| Myosin Light Chains | 2 | 2005 | 23 | 0.130 |
Why?
|
| Neoplasms | 1 | 2020 | 15193 | 0.120 |
Why?
|
| Chlorides | 1 | 2014 | 139 | 0.120 |
Why?
|
| Microtubules | 1 | 2015 | 270 | 0.120 |
Why?
|
| Shear Strength | 1 | 2014 | 35 | 0.120 |
Why?
|
| Ferric Compounds | 1 | 2014 | 73 | 0.120 |
Why?
|
| Platelet Glycoprotein GPIb-IX Complex | 2 | 2014 | 73 | 0.120 |
Why?
|
| Megakaryocytes | 2 | 2008 | 104 | 0.120 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 | 1997 | 2527 | 0.120 |
Why?
|
| Cryoelectron Microscopy | 1 | 2015 | 243 | 0.120 |
Why?
|
| Transfection | 3 | 2012 | 2944 | 0.120 |
Why?
|
| Carotid Arteries | 1 | 2014 | 240 | 0.110 |
Why?
|
| Collagen | 2 | 2013 | 752 | 0.110 |
Why?
|
| RNA, Small Interfering | 2 | 2010 | 2216 | 0.110 |
Why?
|
| Vimentin | 1 | 2014 | 253 | 0.110 |
Why?
|
| Vasculitis | 1 | 2012 | 61 | 0.110 |
Why?
|
| Protein Interaction Mapping | 1 | 2012 | 162 | 0.100 |
Why?
|
| Risk Factors | 4 | 2020 | 17523 | 0.100 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2012 | 280 | 0.100 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2012 | 334 | 0.100 |
Why?
|
| Blood Preservation | 1 | 2011 | 54 | 0.100 |
Why?
|
| Time Factors | 3 | 2014 | 12926 | 0.100 |
Why?
|
| Inflammation | 1 | 2020 | 2522 | 0.090 |
Why?
|
| Receptors, Thrombin | 1 | 2009 | 23 | 0.090 |
Why?
|
| Cryopreservation | 1 | 2011 | 175 | 0.090 |
Why?
|
| Plasma | 1 | 2011 | 158 | 0.090 |
Why?
|
| Secretory Vesicles | 1 | 2009 | 39 | 0.090 |
Why?
|
| Phosphoserine | 1 | 2009 | 107 | 0.090 |
Why?
|
| Cells, Cultured | 2 | 2009 | 5637 | 0.090 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2009 | 163 | 0.090 |
Why?
|
| Phenotype | 2 | 2014 | 6295 | 0.090 |
Why?
|
| Isoenzymes | 2 | 2009 | 614 | 0.090 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2009 | 28 | 0.090 |
Why?
|
| Lipids | 1 | 2013 | 644 | 0.090 |
Why?
|
| Enzyme Inhibitors | 2 | 2009 | 1879 | 0.090 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2009 | 161 | 0.090 |
Why?
|
| Immunoprecipitation | 1 | 2010 | 591 | 0.080 |
Why?
|
| Mitochondria | 1 | 2015 | 1282 | 0.080 |
Why?
|
| Protein Phosphatase 2C | 1 | 2008 | 75 | 0.080 |
Why?
|
| Risk Assessment | 1 | 2020 | 6869 | 0.080 |
Why?
|
| Mice, Inbred BALB C | 2 | 2011 | 2314 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2008 | 639 | 0.080 |
Why?
|
| Peptides | 1 | 2013 | 1479 | 0.070 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2005 | 568 | 0.070 |
Why?
|
| Antibodies | 1 | 2010 | 838 | 0.070 |
Why?
|
| Mice, Transgenic | 1 | 2014 | 4143 | 0.070 |
Why?
|
| Heart Transplantation | 1 | 2014 | 908 | 0.070 |
Why?
|
| DNA Primers | 1 | 2009 | 1399 | 0.070 |
Why?
|
| Glutathione | 1 | 2008 | 368 | 0.070 |
Why?
|
| STAT3 Transcription Factor | 1 | 2012 | 1121 | 0.070 |
Why?
|
| Cytoskeleton | 2 | 2014 | 267 | 0.070 |
Why?
|
| Myosin-Light-Chain Phosphatase | 1 | 2005 | 10 | 0.070 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 2 | 2003 | 215 | 0.070 |
Why?
|
| Densitometry | 1 | 2005 | 45 | 0.070 |
Why?
|
| Cricetulus | 2 | 2008 | 205 | 0.070 |
Why?
|
| Carrier Proteins | 1 | 2013 | 2022 | 0.060 |
Why?
|
| Threonine | 1 | 2005 | 161 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 3639 | 0.060 |
Why?
|
| Heart-Assist Devices | 1 | 2014 | 1171 | 0.060 |
Why?
|
| Tyrosine | 1 | 2005 | 498 | 0.060 |
Why?
|
| Leucine | 1 | 2005 | 352 | 0.060 |
Why?
|
| Receptors, Estrogen | 2 | 2001 | 2086 | 0.060 |
Why?
|
| Conserved Sequence | 1 | 2004 | 469 | 0.060 |
Why?
|
| Base Sequence | 1 | 2009 | 4917 | 0.050 |
Why?
|
| Cell Movement | 2 | 2002 | 2466 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2009 | 2054 | 0.050 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2002 | 315 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2003 | 1062 | 0.050 |
Why?
|
| Cytochalasin D | 1 | 2000 | 19 | 0.050 |
Why?
|
| Biopolymers | 1 | 2000 | 38 | 0.050 |
Why?
|
| Binding Sites | 1 | 2004 | 2171 | 0.040 |
Why?
|
| Heart Failure | 1 | 2014 | 2516 | 0.040 |
Why?
|
| Cell Size | 1 | 2000 | 136 | 0.040 |
Why?
|
| Ovarian Neoplasms | 1 | 2015 | 4638 | 0.040 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2000 | 111 | 0.040 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2000 | 161 | 0.040 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2012 | 1756 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2009 | 6150 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2000 | 644 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2004 | 4233 | 0.040 |
Why?
|
| Pyrimidines | 1 | 2010 | 3518 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2012 | 4757 | 0.040 |
Why?
|
| Point Mutation | 1 | 2000 | 769 | 0.040 |
Why?
|
| Cell Adhesion Molecules | 1 | 2000 | 577 | 0.040 |
Why?
|
| Actins | 1 | 2000 | 608 | 0.040 |
Why?
|
| Neuraminidase | 1 | 1997 | 69 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2009 | 7222 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 3 | 2001 | 5395 | 0.040 |
Why?
|
| Biomarkers, Tumor | 1 | 2015 | 10331 | 0.040 |
Why?
|
| Models, Biological | 1 | 2005 | 3254 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2000 | 803 | 0.030 |
Why?
|
| Testosterone | 1 | 2000 | 619 | 0.030 |
Why?
|
| Bleeding Time | 1 | 2014 | 14 | 0.030 |
Why?
|
| Receptors, Androgen | 1 | 2000 | 878 | 0.030 |
Why?
|
| Toll-Like Receptors | 1 | 2015 | 174 | 0.030 |
Why?
|
| Hot Temperature | 1 | 1995 | 281 | 0.030 |
Why?
|
| Chemokines | 1 | 2015 | 314 | 0.030 |
Why?
|
| Alleles | 1 | 2000 | 2437 | 0.030 |
Why?
|
| Cattle | 1 | 1995 | 783 | 0.030 |
Why?
|
| Leukocytes | 1 | 2015 | 422 | 0.030 |
Why?
|
| Syk Kinase | 1 | 2012 | 56 | 0.030 |
Why?
|
| Phospholipase C gamma | 1 | 2012 | 54 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 1994 | 1618 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 1995 | 554 | 0.030 |
Why?
|
| Female | 4 | 2015 | 141928 | 0.020 |
Why?
|
| Mice, Knockout | 2 | 2012 | 5710 | 0.020 |
Why?
|
| Partial Thromboplastin Time | 1 | 2011 | 55 | 0.020 |
Why?
|
| Kidney | 1 | 2000 | 2146 | 0.020 |
Why?
|
| Solutions | 1 | 2010 | 104 | 0.020 |
Why?
|
| Hemostasis | 1 | 2011 | 109 | 0.020 |
Why?
|
| Thrombelastography | 1 | 2011 | 79 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2014 | 1021 | 0.020 |
Why?
|
| Male | 3 | 2014 | 123000 | 0.020 |
Why?
|
| Estrogen Receptor beta | 2 | 2001 | 155 | 0.020 |
Why?
|
| Purinergic P2 Receptor Agonists | 1 | 2009 | 2 | 0.020 |
Why?
|
| Purinergic P2 Receptor Antagonists | 1 | 2009 | 8 | 0.020 |
Why?
|
| Thromboxanes | 1 | 2009 | 12 | 0.020 |
Why?
|
| Receptors, Purinergic P2Y1 | 1 | 2009 | 19 | 0.020 |
Why?
|
| Protein Stability | 1 | 2010 | 370 | 0.020 |
Why?
|
| Glutathione Disulfide | 1 | 2008 | 20 | 0.020 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2009 | 52 | 0.020 |
Why?
|
| Biomechanical Phenomena | 1 | 2010 | 338 | 0.020 |
Why?
|
| Adenosine Monophosphate | 1 | 2009 | 76 | 0.020 |
Why?
|
| Hemorheology | 1 | 2008 | 45 | 0.020 |
Why?
|
| Adenosine Diphosphate | 1 | 2009 | 113 | 0.020 |
Why?
|
| Oligopeptides | 1 | 2011 | 429 | 0.020 |
Why?
|
| Cell Survival | 1 | 1995 | 3045 | 0.020 |
Why?
|
| Pulsatile Flow | 1 | 2008 | 131 | 0.020 |
Why?
|
| Peptides, Cyclic | 1 | 2009 | 139 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2012 | 1038 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2014 | 2803 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2008 | 717 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2012 | 1265 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2010 | 1487 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2000 | 5539 | 0.020 |
Why?
|
| Cytokines | 1 | 2015 | 2809 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 4938 | 0.020 |
Why?
|
| Atherosclerosis | 1 | 2012 | 935 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 1997 | 4367 | 0.010 |
Why?
|
| Diffusion Chambers, Culture | 1 | 2002 | 9 | 0.010 |
Why?
|
| Vitronectin | 1 | 2002 | 22 | 0.010 |
Why?
|
| Isoantigens | 1 | 2002 | 62 | 0.010 |
Why?
|
| Sialoglycoproteins | 1 | 2002 | 151 | 0.010 |
Why?
|
| Osteopontin | 1 | 2002 | 148 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2002 | 259 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2012 | 6942 | 0.010 |
Why?
|
| Glycosylation | 1 | 2001 | 213 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2002 | 483 | 0.010 |
Why?
|
| RNA Splicing | 1 | 2001 | 370 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2014 | 12873 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 14889 | 0.010 |
Why?
|
| Antigens, CD34 | 1 | 2000 | 593 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2000 | 769 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2000 | 3536 | 0.010 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2000 | 1242 | 0.010 |
Why?
|
| Coronary Artery Disease | 1 | 2001 | 1011 | 0.010 |
Why?
|
| Young Adult | 1 | 2011 | 21445 | 0.010 |
Why?
|
| Adult | 2 | 2011 | 77950 | 0.010 |
Why?
|
| Adolescent | 1 | 2011 | 31252 | 0.010 |
Why?
|
| Mutation | 1 | 2010 | 15179 | 0.010 |
Why?
|
| Middle Aged | 2 | 2011 | 86204 | 0.010 |
Why?
|
| Aged | 1 | 2011 | 70117 | 0.000 |
Why?
|